Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Therapeutic targeting at a pre-metastatic stage for brain metastases from lung cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.10.18
Views: 1079

Dr Sheila Singh - McMaster University, Ontario, Canada

Dr Sheila Singh speaks with ecancer at ESMO 2018 in Munich about techniques for identifying which lung cancer cells are most likely to metastasize.

She describes how, by using mouse models of lung cancer with added green fluorescent protein, a cancer cell can be tracked as it spreads and crosses the blood brain barrier.

These cells can then characterised as a pre-metastatic cell lineage, and Dr Singh describes her hope to improve the understanding of disease progression and metastasis.

ecancer's filming has been kindly supported by MSD through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation